Nanog (Simeticone)

Simeticone, the active ingredient in Nanog, is an antifoaming agent presented as an oral formulation for oral use. It relieves flatulence, abdominal bloating and gas‑related discomfort in adults and children when appropriate. By decreasing surface tension of gas bubbles in the gastrointestinal tract, it facilitates the coalescence and elimination of gas, providing symptomatic relief.

GNH USA supplies Nanog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable distribution to healthcare providers.

Simeticone is used to manage gastrointestinal gas‑related conditions.

Flatulence: Reduces the volume of intestinal gas and associated discomfort, helping patients feel less gassy. Abdominal bloating: Alleviates the sensation of abdominal distension caused by trapped gas, improving comfort after meals. Gas‑related discomfort: Provides symptomatic relief of pain, pressure, and cramping associated with excess gastrointestinal gas.

Simeticone is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: transient feeling of queasiness. - Diarrhea: loose stools occurring shortly after administration. - Constipation: occasional difficulty passing stool. - Taste alteration: temporary metallic or bitter taste.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or severe hypersensitivity. - Respiratory distress: wheezing or difficulty breathing. - Severe abdominal pain: persistent or worsening pain. - Anaphylaxis: rare life‑threatening systemic reaction.

Before using Nanog, consider the following precautions.

Pregnancy: safety not established; use only if clearly needed. Breastfeeding: insufficient data; weigh benefits against potential risks. Pediatric use: dosage determined by healthcare professional; monitor for tolerance. Drug interactions: generally low potential, but review concomitant medications. Medical conditions: patients with known hypersensitivity to simeticone should avoid use. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Simeticone has a low interaction profile, but be aware of the following.

Major Interactions (Avoid): - None identified: Simeticone has no known major drug interactions.

Moderate Interactions (Monitor Closely): - Antacids: may alter gastric environment; monitor efficacy. - Antibiotics: no direct interaction, but observe any changes in gastrointestinal symptoms. - Prokinetics: may affect gas movement; watch for altered response.